Effects of selective serotonin reuptake and dual serotonergic-noradrenergic reuptake treatments on attention and executive functions in patients with major depressive disorder.

@article{HerreraGuzmn2010EffectsOS,
  title={Effects of selective serotonin reuptake and dual serotonergic-noradrenergic reuptake treatments on attention and executive functions in patients with major depressive disorder.},
  author={Ixchel Herrera-Guzm{\'a}n and Jorge E. Herrera-Abarca and Esteve Gudayol-Ferr{\'e} and Daniel Herrera-Guzm{\'a}n and Lizbeth G{\'o}mez-Carbajal and Miriam Pe{\~n}a-Olvira and Erwin Rogelio Villuendas-Gonz{\'a}lez and G. Joan},
  journal={Psychiatry research},
  year={2010},
  volume={177 3},
  pages={323-9}
}
Several reports suggest that antidepressants may improve cognitive functioning in patients with major depressive disorder (MDD). The present work aims to study the effects of selective serotonin reuptake inhibitors (SSRIs) and serotonergic-noradrenergic reuptake inhibitors (SNRIs) treatments on the performance of working memory, attention and executive… CONTINUE READING